BCYC - Bicycle Therapeutics EPS misses by $0.32 beats on revenue March, 11 2021 07:25 AM Bicycle Therapeutics plc Bicycle Therapeutics (BCYC): Q4 GAAP EPS of -$0.83 misses by $0.32.Revenue of $3.85M (-27.1% Y/Y) beats by $0.19M.Press Release For further details see: Bicycle Therapeutics EPS misses by $0.32, beats on revenue